OTUD1 Prevents Immunosuppression via Promoting Lysosomal-Associated Degradation of PD-L1.
文献摘要
Upregulation of PD-L1 on tumor cells is a pivotal aspect of immune evasion, leading to treatment resistance, tumor recurrence, and metastasis. Understanding the mechanisms that control PD-L1 expression in cancer cells is therefore of paramount importance. In this study, we show that deubiquitinase OTUD1 is downregulated in kidney renal clear cell carcinoma (KIRC), and its low expression is linked to a poor prognosis in patients. Analysis of a public single-cell sequencing dataset revealed that OTUD1 is enriched in specific immune cell populations, indicating its potential for immune modulation. Overexpression of OTUD1 significantly hindered KIRC progression and was associated with decreased PD-L1 expression in both KIRC patients and mouse cancer models. Further investigation uncovered that OTUD1 downregulates PD-L1 abundance and enhances tumor cell sensitivity to cytotoxicity mediated by Jurkat T cells. Mechanistically, OTUD1 interacts with and deubiquitinates the protein kinase AKT, thereby promoting the autophagosome-lysosomal degradation of PD-L1 via the AKT-mTOR-TFEB axis. Moreover, OTUD1 overexpression induced autophagy and enhanced the release or exposure of DAMPs, thereby promoting T cell infiltration into the tumor microenvironment in mice. Our study unveils a novel mechanism by which OTUD1 regulates PD-L1 degradation, highlighting its potential as a therapeutic target in KIRC cancer immunology.